184 related articles for article (PubMed ID: 32155098)
1. Transscleral Iontophoresis for Noninvasive Ocular Drug Delivery of Macromolecules.
Molokhia S; Papangkorn K; Butler C; Higuchi JW; Brar B; Ambati B; Li SK; Higuchi WI
J Ocul Pharmacol Ther; 2020 May; 36(4):247-256. PubMed ID: 32155098
[No Abstract] [Full Text] [Related]
2. Transscleral iontophoretic and intravitreal delivery of a macromolecule: study of ocular distribution in vivo and postmortem with MRI.
Molokhia SA; Jeong EK; Higuchi WI; Li SK
Exp Eye Res; 2009 Mar; 88(3):418-25. PubMed ID: 19000673
[TBL] [Abstract][Full Text] [Related]
3. Examination of penetration routes and distribution of ionic permeants during and after transscleral iontophoresis with magnetic resonance imaging.
Molokhia SA; Jeong EK; Higuchi WI; Li SK
Int J Pharm; 2007 Apr; 335(1-2):46-53. PubMed ID: 17236728
[TBL] [Abstract][Full Text] [Related]
4. Iontophoretic transport of charged macromolecules across human sclera.
Chopra P; Hao J; Li SK
Int J Pharm; 2010 Mar; 388(1-2):107-13. PubMed ID: 20045044
[TBL] [Abstract][Full Text] [Related]
5. In vitro permeability of a model protein across ocular tissues and effect of iontophoresis on the transscleral delivery.
Tratta E; Pescina S; Padula C; Santi P; Nicoli S
Eur J Pharm Biopharm; 2014 Sep; 88(1):116-22. PubMed ID: 24816128
[TBL] [Abstract][Full Text] [Related]
6. Ultrasound-mediated transscleral delivery of macromolecules to the posterior segment of rabbit eye in vivo.
Suen WL; Wong HS; Yu Y; Lau LC; Lo AC; Chau Y
Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4358-65. PubMed ID: 23722390
[TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance imaging study of current and ion delivery into the eye during transscleral and transcorneal iontophoresis.
Li SK; Jeong EK; Hastings MS
Invest Ophthalmol Vis Sci; 2004 Apr; 45(4):1224-31. PubMed ID: 15037591
[TBL] [Abstract][Full Text] [Related]
8. Transscleral passive and iontophoretic transport: theory and analysis.
Li SK; Hao J
Expert Opin Drug Deliv; 2018 Mar; 15(3):283-299. PubMed ID: 29149574
[TBL] [Abstract][Full Text] [Related]
9. Assessment of subconjunctival delivery with model ionic permeants and magnetic resonance imaging.
Li SK; Molokhia SA; Jeong EK
Pharm Res; 2004 Dec; 21(12):2175-84. PubMed ID: 15648248
[TBL] [Abstract][Full Text] [Related]
10. Enhanced transscleral lontophoretic transport with ion-exchange membrane.
Li SK; Zhu H; Higuchi WI
Pharm Res; 2006 Aug; 23(8):1857-67. PubMed ID: 16841198
[TBL] [Abstract][Full Text] [Related]
11. Examination of barriers and barrier alteration in transscleral iontophoresis.
Molokhia SA; Jeong EK; Higuchi WI; Li SK
J Pharm Sci; 2008 Feb; 97(2):831-44. PubMed ID: 17879296
[TBL] [Abstract][Full Text] [Related]
12. In-vitro permeation of bevacizumab through human sclera: effect of iontophoresis application.
Pescina S; Ferrari G; Govoni P; Macaluso C; Padula C; Santi P; Nicoli S
J Pharm Pharmacol; 2010 Sep; 62(9):1189-94. PubMed ID: 20796199
[TBL] [Abstract][Full Text] [Related]
13. Characterization of human sclera barrier properties for transscleral delivery of bevacizumab and ranibizumab.
Wen H; Hao J; Li SK
J Pharm Sci; 2013 Mar; 102(3):892-903. PubMed ID: 23212655
[TBL] [Abstract][Full Text] [Related]
14. Effect of formulation factors on the trans-scleral iontophoretic and post-iontophoretic transports of a 40 kDa dextran in vitro.
Pescina S; Padula C; Santi P; Nicoli S
Eur J Pharm Sci; 2011 Apr; 42(5):503-8. PubMed ID: 21352911
[TBL] [Abstract][Full Text] [Related]
15. Influence of asymmetric donor-receiver ion concentration upon transscleral iontophoretic transport.
Li SK; Zhang Y; Zhu H; Higuchi WI; White HS
J Pharm Sci; 2005 Apr; 94(4):847-60. PubMed ID: 15736190
[TBL] [Abstract][Full Text] [Related]
16. Methotrexate delivery to the eye using transscleral hydrogel iontophoresis.
Eljarrat-Binstock E; Domb AJ; Orucov F; Frucht-Pery J; Pe'er J
Curr Eye Res; 2007; 32(7-8):639-46. PubMed ID: 17852187
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo evaluation of carboplatin delivery to the eye using hydrogel-iontophoresis.
Eljarrat-Binstock E; Domb AJ; Orucov F; Dagan A; Frucht-Pery J; Pe'er J
Curr Eye Res; 2008 Mar; 33(3):269-75. PubMed ID: 18350438
[TBL] [Abstract][Full Text] [Related]
18. Contact Lens Based Drug Delivery to the Posterior Segment Via Iontophoresis in Cadaver Rabbit Eyes.
Christopher K; Chauhan A
Pharm Res; 2019 Apr; 36(6):87. PubMed ID: 31004227
[TBL] [Abstract][Full Text] [Related]
19. Three-Dimensional Transport Model for Intravitreal and Suprachoroidal Drug Injection.
Zhang Y; Bazzazi H; Lima E Silva R; Pandey NB; Green JJ; Campochiaro PA; Popel AS
Invest Ophthalmol Vis Sci; 2018 Oct; 59(12):5266-5276. PubMed ID: 30383198
[TBL] [Abstract][Full Text] [Related]
20. Suprachoroidal delivery of bevacizumab in rabbit in vivo eyes: Rapid distribution throughout the posterior segment.
Sher I; Goldberg Z; Bubis E; Barak Y; Rotenstreich Y
Eur J Pharm Biopharm; 2021 Dec; 169():200-210. PubMed ID: 34662718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
